Publications
Facts from IQVIA, 6 months 2024: Eurasian pharmaceutical markets in numbers
The pharmaceutical markets in Eurasia are on the rise, with retail leading the charge, accounting for 58% of total sales. Rx products dominate, making up 60-70% of all sales and underscoring…
Analysis of key trends in the pharmaceutical markets of Central Asia from Proxima Research
Pharmaceutical markets in Central Asia have shown impressive growth in the first half of this year, according to Proxima Research. Kazakhstan and Uzbekistan, in particular, posted double-digit grow…
Anastasia Kruglova: “The top challenge in Eurasian markets is the low or nonexistent reimbursement levels”
As we gear up for the 5th Eurasian Pharmaceutical Summit, the Global Pharmaceutical Leaders’ Club presents an exclusive interview with Anastasia Kruglova, General Director of IQVIA in Russia and…
Viktoriya Spivak: “In Kazakhstan and Uzbekistan, our competitive edge is in offering premium tertiary Sell Out data”
In the lead-up to the Eurasian Pharmaceutical Summit, set for September 17-19 in a hybrid format with an offline part in Tashkent, Natalia Baeva, Director of the Global Pharmaceutical Leaders’…
Vladislav Bessarabov: “We’re eager to ramp up our presence in Kazakhstan and expand our portfolio”
Vladislav Bessarabov, Head of Strategic Business Unit Eurasia at Bosnalijek, gave an interview to Natalia Baeva, Director of the Global Pharmaceutical Leaders’ Club at the Kazakhstan…
Proxima Research: Kazakhstan and Uzbekistan showed growth in pharma markets early 2024
In the first quarter of 2024, the largest pharmaceutical markets in Central Asia grew: Kazakhstan’s retail market increased by 5%, and Uzbekistan’s by 8%. These insights come from Proxima…
Proxima Research is the Analytical Partner of the 5th Eurasian Pharmaceutical Summit
Global Pharmaceutical Leaders’ Club is pleased to announce Proxima Research as the “Analytical Partner” for the 2024 Eurasian Pharmaceutical Summit taking place in Tashkent and online on the 17th…
IQVIA has become the Partner of the 5th Eurasian Pharmaceutical Summit
The Global Pharmaceutical Leaders’ Club is pleased to announce that IQVIA has become the Partner of the Eurasian Pharmaceutical Summit 2024….
AstraZeneca has become a Pharmaceutical Partner of the 5th Eurasian Pharmaceutical Summit
Global Pharmaceutical Leaders’ Club announces that AstraZeneca has joined the Eurasian Pharmaceutical Summit 2024 as a Pharmaceutical Partner. AstraZeneca stands at the forefront of the biophar…